Literature DB >> 21468087

Long-lasting protection in brain trauma by endotoxin preconditioning.

Luca Longhi1, Raffaella Gesuete, Carlo Perego, Fabrizio Ortolano, Noemi Sacchi, Pia Villa, Nino Stocchetti, Maria-Grazia De Simoni.   

Abstract

We investigated the occurrence of endotoxin (lipopolysaccharide, LPS) preconditioning in traumatic brain injury (TBI), evaluating the time window of LPS-induced protection, its persistence, and the associated molecular mechanisms. Mice received 0.1 mg/kg LPS or saline intraperitoneally and subsequently TBI (by controlled cortical impact brain injury) at various time intervals. Mice receiving LPS 3, 5, or 7 days before TBI showed attenuated motor deficits at 1 week after injury compared with mice receiving saline. Those receiving LPS 5 days before injury had also a reduced contusion volume (7.9±1.3 versus 12±2.3 mm(3)) and decreased cell death. One month after injury, the protective effect of LPS on contusion volume (14.5±1.2 versus 18.2±1.2 mm(3)) and neurologic function was still present. Traumatic brain injury increased glial fibrillary acidic protein, CD11b, CD68, tumor necrosis factor-α, interleukin (IL)-10, and IL-6 mRNA expression 24 hours after injury. Lipopolysaccharide administered 5 (but not 9) days before injury increased the expression of CD11b (233%) and of interferon β (500%) in uninjured mice, while it reduced the expression of CD68 (by 46%) and increased that of IL-6 (by 52%) in injured mice. Lipopolysaccharide preconditioning conferred a long-lasting neuroprotection after TBI, which was associated with a modulation of microglia/macrophages activity and cytokine production.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21468087      PMCID: PMC3185879          DOI: 10.1038/jcbfm.2011.42

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  41 in total

Review 1.  Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.

Authors:  Ulrich Dirnagl; Kyra Becker; Andreas Meisel
Journal:  Lancet Neurol       Date:  2009-04       Impact factor: 44.182

2.  Heat acclimation provides sustained improvement in functional recovery and attenuates apoptosis after traumatic brain injury.

Authors:  Gali Umscheif; Gali Umschwief; Na'ama A Shein; Alexander G Alexandrovich; Victoria Trembovler; Michal Horowitz; Esther Shohami
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-11       Impact factor: 6.200

Review 3.  Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury.

Authors:  Jenna M Ziebell; Maria Cristina Morganti-Kossmann
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

4.  Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial.

Authors:  Hans Erik Bøtker; Rajesh Kharbanda; Michael R Schmidt; Morten Bøttcher; Anne K Kaltoft; Christian J Terkelsen; Kim Munk; Niels H Andersen; Troels M Hansen; Sven Trautner; Jens Flensted Lassen; Evald Høj Christiansen; Lars R Krusell; Steen D Kristensen; Leif Thuesen; Søren S Nielsen; Michael Rehling; Henrik Toft Sørensen; Andrew N Redington; Torsten T Nielsen
Journal:  Lancet       Date:  2010-02-27       Impact factor: 79.321

5.  Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3.

Authors:  Brenda Marsh; Susan L Stevens; Amy E B Packard; Banu Gopalan; Brian Hunter; Philberta Y Leung; Christina A Harrington; Mary P Stenzel-Poore
Journal:  J Neurosci       Date:  2009-08-05       Impact factor: 6.167

Review 6.  Moderate and severe traumatic brain injury in adults.

Authors:  Andrew I R Maas; Nino Stocchetti; Ross Bullock
Journal:  Lancet Neurol       Date:  2008-08       Impact factor: 44.182

7.  c-Jun N-terminal kinase pathway activation in human and experimental cerebral contusion.

Authors:  Fabrizio Ortolano; Alessio Colombo; Elisa Roncati Zanier; Allessandra Sclip; Luca Longhi; Carlo Perego; Nino Stocchetti; Tiziana Borsello; Maria Grazia De Simoni
Journal:  J Neuropathol Exp Neurol       Date:  2009-09       Impact factor: 3.685

Review 8.  Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects.

Authors:  Shigeaki Suzuki; Kortaro Tanaka; Norihiro Suzuki
Journal:  J Cereb Blood Flow Metab       Date:  2008-11-19       Impact factor: 6.200

9.  C1-inhibitor attenuates neurobehavioral deficits and reduces contusion volume after controlled cortical impact brain injury in mice.

Authors:  Luca Longhi; Carlo Perego; Fabrizio Ortolano; Elisa R Zanier; Paolo Bianchi; Nino Stocchetti; Tracy K McIntosh; Maria Grazia De Simoni
Journal:  Crit Care Med       Date:  2009-02       Impact factor: 7.598

10.  Differential neuroprotective properties of endogenous and exogenous erythropoietin in a mouse model of traumatic brain injury.

Authors:  Na'ama A Shein; Nikolaos Grigoriadis; Alexander G Alexandrovich; Constantina Simeonidou; Evangelia Spandou; Jeanna Tsenter; Ido Yatsiv; Michal Horowitz; Esther Shohami
Journal:  J Neurotrauma       Date:  2008-02       Impact factor: 5.269

View more
  37 in total

Review 1.  Emergence of SARM1 as a Potential Therapeutic Target for Wallerian-type Diseases.

Authors:  Heather S Loring; Paul R Thompson
Journal:  Cell Chem Biol       Date:  2019-11-21       Impact factor: 8.116

Review 2.  Microglial phenotype and adaptation.

Authors:  B J L Eggen; D Raj; U-K Hanisch; H W G M Boddeke
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-25       Impact factor: 4.147

3.  Attenuated traumatic axonal injury and improved functional outcome after traumatic brain injury in mice lacking Sarm1.

Authors:  Nils Henninger; James Bouley; Elif M Sikoglu; Jiyan An; Constance M Moore; Jean A King; Robert Bowser; Marc R Freeman; Robert H Brown
Journal:  Brain       Date:  2016-02-11       Impact factor: 13.501

4.  Pharmacological inhibition of mannose-binding lectin ameliorates neurobehavioral dysfunction following experimental traumatic brain injury.

Authors:  Daiana De Blasio; Stefano Fumagalli; Luca Longhi; Franca Orsini; Alessandro Palmioli; Matteo Stravalaci; Gloria Vegliante; Elisa R Zanier; Anna Bernardi; Marco Gobbi; Maria-Grazia De Simoni
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-20       Impact factor: 6.200

Review 5.  Mitochondrial mechanisms in cerebral vascular control: shared signaling pathways with preconditioning.

Authors:  David W Busija; Prasad V Katakam
Journal:  J Vasc Res       Date:  2014-05-22       Impact factor: 1.934

Review 6.  Preconditioning for traumatic brain injury.

Authors:  Shoji Yokobori; Anna T Mazzeo; Khadil Hosein; Shyam Gajavelli; W Dalton Dietrich; M Ross Bullock
Journal:  Transl Stroke Res       Date:  2012-11-15       Impact factor: 6.829

Review 7.  Chronic Histopathological and Behavioral Outcomes of Experimental Traumatic Brain Injury in Adult Male Animals.

Authors:  Nicole D Osier; Shaun W Carlson; Anthony DeSana; C Edward Dixon
Journal:  J Neurotrauma       Date:  2015-04-15       Impact factor: 5.269

8.  Should the STAIR criteria be modified for preconditioning studies?

Authors:  Michael M Wang; Guohua Xi; Richard F Keep
Journal:  Transl Stroke Res       Date:  2013-02       Impact factor: 6.829

9.  Tumor necrosis factor in traumatic brain injury: effects of genetic deletion of p55 or p75 receptor.

Authors:  Luca Longhi; Carlo Perego; Fabrizio Ortolano; Silvia Aresi; Stefano Fumagalli; Elisa R Zanier; Nino Stocchetti; Maria-Grazia De Simoni
Journal:  J Cereb Blood Flow Metab       Date:  2013-04-24       Impact factor: 6.200

Review 10.  The Controlled Cortical Impact Model of Experimental Brain Trauma: Overview, Research Applications, and Protocol.

Authors:  Nicole Osier; C Edward Dixon
Journal:  Methods Mol Biol       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.